GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of reading API source threads from 2024 and half of it aged badly — 27 comments in the full submission. View in context.
633
c/compounding·submitted 1 months ago by u/lina_ndiaye

reading API source threads from 2024 and half of it aged badly

Discussionbranch of 9 comments

Been lurking in c/trialwatch for about 9 months and finally have something worth posting. Short version: week 3, 2.4mg, and compounding is the bit I still cannot get a straight answer on. I have read the wiki, I have read the last 25 threads, and the answers split roughly down the middle. What I actually want to know…

Read the full submission and all 27 comments →

This branch

9 comments, started 1 months ago
u/mateusz_adebayo145 points·1 months ago

Asked 13 compounders about API source. One told me, one dodged, one said they cannot say. The answer is the signal.

replysharereportpermalink
[deleted]106 points·29 days ago

[deleted]

replysharereportpermalink
u/jonas_eriksen52 points·29 days ago

Yeah, 503A and 503B are different regulatory animals.

replysharereportpermalink
u/naomi_erdogan112 points·1 months ago·edited

Asked 13 compounders about API source.

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

replysharereportpermalink
u/escrow_evangelist65 points·29 days ago·edited

state board rules differ, say which state

replysharereportpermalink
u/eu_apotheke_a33 points·29 days ago

Slight fix: the number was 95.1, not 94.2. Decimal point, but a fairly consequential one.

replysharereportpermalink
u/quiet_moderatorMOD102 points·1 months ago

Flair changed to match the content. Read the sidebar before posting next time and we are square.

replysharereportpermalink
u/rafael_ostergaard84 points·29 days ago

regulatory claims need a citation to the actual rule, not interpretation

replysharereportpermalink
u/slow_logbook-34 points·29 days ago

Strongly agree. API source transparency matters.

replysharereportpermalink

← back to the whole thread

About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.